Liffert Vogt
Liffert Vogt
Amsterdam University Medical Center, University of Amsterdam, The Netherlands
Verified email at amc.nl
Title
Cited by
Cited by
Year
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
AIR Maas, DK Menon, PD Adelson, N Andelic, MJ Bell, A Belli, P Bragge, ...
The Lancet Neurology 16 (12), 987-1048, 2017
5132017
CLINICAL PERSPECTIVE
BK Mahmoodi, JLP Brouwer, NJGM Veeger, J van der Meer
Circulation 118 (16), 1659-1667, 2008
408*2008
Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan
L Vogt, F Waanders, F Boomsma, D de Zeeuw, G Navis
Journal of the American Society of Nephrology 19 (5), 999-1007, 2008
3232008
Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuricá…
F Waanders, VS Vaidya, H van Goor, H Leuvenink, K Damman, ...
American journal of kidney diseases 53 (1), 16-25, 2009
1382009
Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis
RHG Olde Engberink, WJ Frenkel, B van den Bogaard, LM Brewster, ...
Hypertension 65 (5), 1033-1040, 2015
902015
Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease
CRC Doorenbos, M Milton, L Vogt, IP Kema, J van den Born, ROB Gans, ...
The Journal of steroid biochemistry and molecular biology 128 (1-2), 56-61, 2012
632012
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ...
The Lancet 393 (10184), 1937-1947, 2019
622019
Tyrosine kinase inhibition and grey hair
C Robert, A Spatz, S Faivre, JP Armand, E Raymond
The Lancet 361 (9362), 1056, 2003
562003
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
CR Swanepoel, MG Atta, VD D’Agati, MM Estrella, AB Fogo, S Naicker, ...
Kidney international 93 (3), 545-559, 2018
552018
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blindá…
L Vogt, G Navis, J K÷ster, AJ Manolis, JL Reid, D de Zeeuw
Journal of hypertension 23 (11), 2055-2061, 2005
492005
Use of a single baseline versus multiyear 24-hour urine collection for estimation of long-term sodium intake and associated cardiovascular and renal risk
RHG Olde Engberink, TC van den Hoek, ND van Noordenne, ...
Circulation 136 (10), 917-926, 2017
462017
Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus–Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virusá…
KW Kooij, L Vogt, FWNM Wit, M van der Valk, RA van Zoest, A Goorhuis, ...
The Journal of infectious diseases 216 (6), 622-631, 2017
422017
Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study
F Amraoui, S Bos, L Vogt, BJ van den Born
BMC nephrology 13 (1), 71, 2012
412012
Role of the vascular wall in sodium homeostasis and salt sensitivity
RHGO Engberink, NMG Rorije, JJH van der Heide, BJH van den Born, ...
Journal of the American Society of Nephrology 26 (4), 777-783, 2015
392015
Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis
L van der Tol, E Svarstad, A Ortiz, C T°ndel, JP Oliveira, L Vogt, S Waldek, ...
Molecular Genetics and Metabolism 114 (2), 242-247, 2015
392015
Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?
L Vogt, G Navis, D de Zeeuw
Journal of the American Society of Nephrology 16 (3 suppl 1), S53-S57, 2005
392005
on behalf of the Angiotensin II Receptor Antagonist Telmisartan Micardis in Isolated Systolic Hypertension (ARAMIS) Study Group. The angiotensin II receptor antagonistá…
L Vogt, G Navis, J Koster, AJ Manolis, JL Reid, D De Zeeuw
J hypertens 23 (2055), 61, 2005
392005
Arterial and cellular inflammation in patients with CKD
SJB Moens, SL Verweij, FM van der Valk, JC van Capelleveen, J Kroon, ...
Journal of the American Society of Nephrology 28 (4), 1278-1285, 2017
382017
Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy
L Vogt, C Chiurchiu, H Chadha-Boreham, P Danaietash, J Dingemanse, ...
Hypertension 55 (5), 1206-1209, 2010
382010
SFlt-1 elevates blood pressure by augmenting endothelin-1-mediated vasoconstriction in mice
F Amraoui, L Spijkers, HH Lahsinoui, L Vogt, J van der Post, S Peters, ...
PloS one 9 (3), e91897, 2014
372014
The system can't perform the operation now. Try again later.
Articles 1–20